Measuring progress on preventing pneumonia deaths: are we there yet?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it.

1. Vitamin C supplementation for prevention and treatment of pneumonia.The Cochrane database of systematic reviews · 2021
   Pooled it
2. Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO-defined non-severe pneumonia and wheeze.The Cochrane database of systematic reviews · 2021
   Pooled it
3. Vitamin C supplementation for prevention and treatment of pneumonia.The Cochrane database of systematic reviews · 2020
   Pooled it
4. Spatial variability in the association of ambient PMEnvironmental research · 2026
   Article
5. AI-driven diagnosis of pneumococcal infections in children-a call for primary-care focused and a coherent evidence base.Frontiers in artificial intelligence · 2026
   Review
6. Predictors of severity and prolonged hospital stay of viral acute respiratory infections (ARI) among children under five years in Burkina Faso, 2016-2019.BMC infectious diseases · 2024
   Article
7. Convergent impact of vaccination and antibiotic pressures on pneumococcal populations.Cell chemical biology · 2024
   Review
8. Sustainability of pneumococcal conjugate vaccination in Ghana: a cost-effectiveness analysis in the context of donor transition.Frontiers in public health · 2024
   Article
9. Machine learning predictive modelling for identification of predictors of acute respiratory infection and diarrhoea in Uganda's rural and urban settings.PLOS global public health · 2022
   Article
10. Gold-Oligonucleotide Nanoconstructs Engineered to Detect Conserved Enteroviral Nucleic Acid Sequences.Biosensors · 2021
    Article
11. Evaluation of current practice of antimicrobial use and clinical outcome of patients with pneumonia at a tertiary care hospital in Ethiopia: A prospective observational study.PloS one · 2020
    Observational
12. Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis.The Lancet. Global health · 2019
    Article

Corrections and comments

• Comment on
  Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015.2017

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as